Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapy

Antimicrob Agents Chemother. 2002 Mar;46(3):896-9. doi: 10.1128/AAC.46.3.896-899.2002.

Abstract

For a number of antiretroviral drugs, prolonged suppression of viral replication is related to drug exposure. Therefore, it is important to maintain stable concentrations during prolonged therapy. While studies suggest that saquinavir concentrations decrease over time, we show that concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid are stable during 2 years of therapy.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / blood
  • Anti-HIV Agents / cerebrospinal fluid
  • Anti-HIV Agents / pharmacokinetics*
  • Area Under Curve
  • Humans
  • Long-Term Care
  • Male
  • Middle Aged
  • Phosphorylation
  • Time Factors

Substances

  • Anti-HIV Agents